"Teach" the immune system to cope with HIV will help the new vaccine
Researchers from Hospital Clinic Barcelona are developing a vaccine that could have revolutionary implications in the fight against AIDS. She "retrains" the immune system, altering its response to the attack of the virus.
In clinical trials, 24 volunteers took part, the majority of which are more than 24 weeks, a significant reduction in the concentration of virus in the blood. Previous studies of other vaccines have shown a much more modest results – 30% of patients, writes The Telegraph.
This vaccine was made from the dendritic cells of the patients themselves. This is a special type of cell that is a key regulator of the immune system. The cells were extracted and "retrained" to attack the virus using samples of HIV also taken from these patients. During the next two weeks, the corrected cells back to its original location.
New method is much cheaper antiretroviral drugs, whose cost amounts to about 8,000 euros a year. In the course of standard therapy, the patient should take them every day for life.